Coverage
-
January 21, 2016
A New Jersey federal judge Thursday released Johnson Matthey Inc. from Shire LLC's suit accusing it of infringing patents on attention deficit hyperactivity disorder drug Vyvanse, nearly four months after the Federal Circuit ruled Johnson Matthey could not be held liable for supplying generics makers with ingredients.
1 other articles on this case.
View all »